Fomepizole


Thông tin thuốc gốc
Chỉ định và Liều dùng
Intravenous
Ethylene glycol poisoning, Methanol poisoning
Adult: Loading dose: 15 mg/kg followed by 10 mg/kg 12 hourly for 4 doses, then increase dose to 15 mg/kg 12 hourly until ethylene glycol or methanol serum concentrations are <20 mg/100 mL. Doses are given via slow infusion over 30 minutes.
Suy thận
In patients with renal failure, significant worsening metabolic acidosis or ≥50 mg/dL ethylene glycol or methanol serum concentrations requiring haemodialysis: Increase frequency to 4 hourly during haemodialysis. Doses to be given prior to or after haemodialysis are determined based on time of last administered dose or time of haemodialysis (refer to detailed product guideline).
Hướng dẫn pha thuốc
Withdraw appropriate dose from a vial and dilute with at least 100 mL of NaCl 0.9% inj or dextrose 5% inj.
Thận trọng
Renal and hepatic impairment. Pregnancy and Lactation.
Tác dụng không mong muốn
Blood and lymphatic system disorders: Anaemia.
Gastrointestinal disorders: Abdominal pain, vomiting.
General disorders and admin site conditions: Fever.
Nervous system disorders: Headache, agitation.
Vascular disorders: Hypotension.
Chỉ số theo dõi
Monitor for serum plasma or urinary concentrations of ethylene glycol or methanol, plasma/urinary osmolality; urinary oxalate crystals; arterial blood gas, anion and osmolar gaps, electrolytes, urinalysis, renal and LFT, CBC, ECG; EEG (in comatose).
Quá liều
Symptoms: Nausea, dizziness and vertigo. Management: May perform haemodialysis.
Tương tác
May decrease the rate of elimination of ethanol and similarly, ethanol may decrease the rate of elimination of fomepizole. May produce reciprocal interactions with CYP450 inducers (e.g. carbamazepine, phenytoin) or CYP450 inhibitors (e.g. cimetidine, ketoconazole).
Tác dụng
Description:
Mechanism of Action: Fomepizole is a competitive inhibitor of alcohol dehydrogenase, an enzyme that catalyses the oxidation of ethanol to acetaldehyde and the metabolism of ethylene glycol and methanol to their toxic metabolites.
Onset: Peak effect: Approx 1.5-2 hours.
Pharmacokinetics:
Absorption: Readily absorbed from the gastrointestinal tract but usually given via IV.
Distribution: Rapidly distributed into total body water. Volume of distribution: 0.6-1.02 L/kg. Negligible protein binding.
Metabolism: Metabolised in the liver to primary metabolite 4-carboxypyrazole, and other metabolites, 4-hydroxymethylpyrazole and N-glucuronide conjugate; rapidly induces its own metabolism by CYP450 enzymes after multiple doses, resulting to increased rate of elimination.
Excretion: Via urine (1-3.5% as unchanged drug and metabolites). Elimination half-life: Varies with dose.
Đặc tính

Chemical Structure Image
Fomepizole

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 3406, Fomepizole. https://pubchem.ncbi.nlm.nih.gov/compound/Fomepizole. Accessed Nov. 24, 2020.

Bảo quản
Store below 25°C. Protect from light. Diluted solution: Store between 2-8°C for not more than 24 hours.
Phân loại MIMS
Thuốc giải độc & khử độc
Phân loại ATC
V03AB34 - fomepizole ; Belongs to the class of antidotes. Used in the management of ethylene glycol or methanol poisoning.
Tài liệu tham khảo
AFT Pharmaceuticals Ltd. Antizol 1 g/mL Concentrate for Injection data sheet February 2019. Medsafe. http://www.medsafe.govt.nz/. Accessed 29/10/2020.

Anon. Fomepizole. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 29/10/2020.

Anon. Fomepizole. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 29/10/2020.

Antizol Injection (Paladin Laboratories USA Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 29/10/2020.

Buckingham R (ed). Fomepizole. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 29/10/2020.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Fomepizole từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in